Login / Signup

5-azacitidine reversing "spent" phase polycythemia vera back to proliferative phase and need for phlebotomy.

Jaren LernerMiguel Michel OcampoConstantin A Dasanu
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
Reversal of a "spent" phase by 5-azacitidine back to a proliferative polycythemia vera phase requiring phlebotomies has not been previously reported in the scientific literature. We might witness similar cases in the literature in the future years, which could lead to yet another therapeutic indication of this important pharmacologic agent.
Keyphrases
  • systematic review
  • acute myeloid leukemia